Cargando…

Recurrent In-Stent Restenosis in a Symptomatic Nonatherosclerotic M1 Plaque: Successful Treatment with Paclitaxel-Eluting Balloon Dilatation after Repeated Failure of Conventional Balloon Reangioplasty

Detalles Bibliográficos
Autores principales:	Güthe, T., Miloslavski, E., Vajda, Z., Peters, J., Bäzner, H., Henkes, H.
Formato:	Texto
Lenguaje:	English
Publicado:	Urban and Vogel 2010
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933851/ https://www.ncbi.nlm.nih.gov/pubmed/20512301 http://dx.doi.org/10.1007/s00062-010-0012-y

Ejemplares similares

Prevention of Intracranial In-stent Restenoses: Predilatation with a Drug Eluting Balloon, Followed by the Deployment of a Self-Expanding Stent
por: Vajda, Zsolt, et al.
Publicado: (2012)

Treatment of Intracranial Atherosclerotic Disease with a Balloon-Expandable Paclitaxel Eluting Stent: Procedural Safety, Efficacy and Mid-Term Patency
por: Vajda, Z., et al.
Publicado: (2012)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
por: Pleva, Leos, et al.
Publicado: (2017)

Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
por: Nijhoff, Freek, et al.
Publicado: (2015)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Two Years Efficacy of Paclitaxel-Coated Balloon Dilation for In-Stent Renal Artery Restenosis Due to Takayasu Arteritis
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Intra-Aortic Balloon Pump Entrapment in a Nonatherosclerotic Common Iliac Artery
por: Sabzi, Feridoun, et al.
Publicado: (2011)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis
por: Wu, Haokun, et al.
Publicado: (2022)

Local drug-delivery balloon for proliferative occlusive in-stent restenosis after drug-eluting stent
por: Rigatelli, Gianluca, et al.
Publicado: (2011)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty – case report and review of the literature
por: Vassilev, Dobrin, et al.
Publicado: (2015)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
por: Cui, Kong-Yong, et al.
Publicado: (2018)

Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies
por: Gao, Lei, et al.
Publicado: (2019)

Paclitaxel-coated balloon dilation for central airway obstruction
por: Sakata, Kenneth K., et al.
Publicado: (2018)

Associations Between Target Lesion Restenosis and Drug-Eluting Balloon Use: An Observational Study
por: Lee, Wei-Chieh, et al.
Publicado: (2016)

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis
por: Lee, Wei-Chieh, et al.
Publicado: (2015)

Intrastent haematoma after treatment with a drug-eluting balloon for in-stent restenosis: a case report
por: Hong, Xu-Lin, et al.
Publicado: (2021)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial
por: Jun, Eun Jung, et al.
Publicado: (2022)

Stent Optimization Using Adjunctive Balloon Dilatation in the Era of Second-Generation Drug-Eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2017)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

Coronary Artery Perforation After Balloon Dilatation for Recurrent In-Stent Restenosis Inside the Double-Layered Previous Stents
por: Yamashita, Daichi, et al.
Publicado: (2023)

A retrospective study from a single center to compare outcomes in 79 patients with in-stent restenosis treated with paclitaxel-coated balloon angioplasty or drug-eluting stent implantation
por: Ben Abdessalem, Mohamed Aymen, et al.
Publicado: (2023)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Cutaneous polyarteritis nodosa resulting from a paclitaxel-eluting balloon angioplasty
por: Montgomery, Allison, et al.
Publicado: (2017)

Analysis of Potential Cost-Savings After Introduction of Drug-Eluting Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
por: Park, Kyungil, et al.
Publicado: (2011)

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study
por: Murnaghan, Kyle, et al.
Publicado: (2022)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Drug-eluting balloon: is it useful?
por: Laksono, Sidhi, et al.
Publicado: (2020)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
por: Peng, Nina, et al.
Publicado: (2020)

Intracranial thrombectomy using the Solitaire stent: a historical vignette
por: Pérez, Marta Aguilar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b6fil6vpq96tgtp9f7n9v1n7vi